Jaguar Health's 15-min chart shows Bollinger Bands Narrowing, KDJ Death Cross.
PorAinvest
viernes, 9 de mayo de 2025, 12:46 pm ET1 min de lectura
JAGX--
The San Francisco-based company has received a "strong buy" rating from Wall Street, with a median 12-month price target of $16.00, above its last closing price of $8.70. The mean earnings estimate has remained unchanged over the past three months.
In addition to the financial outlook, technical analysis of Jaguar Health's stock has shown recent narrowing of Bollinger Bands, suggesting decreasing stock price fluctuations. This was coupled with a KDJ Death Cross on May 9, 2025, at 12:30, signaling a potential shift in momentum towards the downside. This could indicate a continued decline in stock price volatility and a potential decrease in stock price magnitude.
Investors should closely monitor Jaguar Health's earnings report and the ongoing technical indicators to assess the potential impact on the company's stock price.
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3RH2B6:0-jaguar-health-inc-expected-to-post-a-loss-of-18-00-a-share-earnings-preview/
Jaguar Health's 15-minute chart has recently exhibited Bollinger Bands Narrowing, a signal indicating decreasing stock price fluctuations, coupled with a KDJ Death Cross at 05/09/2025 12:30. This suggests that the momentum of the stock price is shifting towards the downside and may continue to decrease in magnitude.
Jaguar Health Inc (JAGX) is set to release its quarterly earnings on May 12, 2025, with analysts expecting a notable increase in revenue. According to one analyst estimate, the company is projected to report a 20.0% rise in revenue to $2.821 million, up from $2.35 million a year ago [1]. However, the earnings preview also indicates a potential loss of $18.00 per share, based on the mean analyst estimate from LSEG data.The San Francisco-based company has received a "strong buy" rating from Wall Street, with a median 12-month price target of $16.00, above its last closing price of $8.70. The mean earnings estimate has remained unchanged over the past three months.
In addition to the financial outlook, technical analysis of Jaguar Health's stock has shown recent narrowing of Bollinger Bands, suggesting decreasing stock price fluctuations. This was coupled with a KDJ Death Cross on May 9, 2025, at 12:30, signaling a potential shift in momentum towards the downside. This could indicate a continued decline in stock price volatility and a potential decrease in stock price magnitude.
Investors should closely monitor Jaguar Health's earnings report and the ongoing technical indicators to assess the potential impact on the company's stock price.
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3RH2B6:0-jaguar-health-inc-expected-to-post-a-loss-of-18-00-a-share-earnings-preview/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios